NASDAQ
Acumen Pharmaceuticals, Inc. (ABOS) has a fcf yield of -90.48% as of Friday, May 29, 2026. This represents a 178.97% decrease compared to its 12-month average of -32.44%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.